Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebral microdialysis to determine brain penetration of antibiotics in neurointensive care patients
2011-002758-29Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of doripenem in Central nervous system infection (3 arms), sponsored by Medical University of Vienna. Primary endpoint: Brain and plasma doripenem PK parameters. Started Apr 2012; status: completed.
02
Drugs
doripenem
03
Conditions
Central nervous system infection
Beyond the preview
Go deeper on 2011-002758-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002758-29.